Structural basis of West Nile virus neutralization by a therapeutic antibody.
Structural basis of West Nile virus neutralization by a therapeutic antibody.
复制标题
DOI:
10.1038/nature03956
复制
发表时间:
2005-09-29
期刊:
影响因子:
64.8
通讯作者:
Fremont DH
中科院分区:
文献类型:
--
作者:
Nybakken GE;Oliphant T;Johnson S;Burke S;Diamond MS;Fremont DH
West Nile virus is closely related to the human epidemic-causing dengue, yellow fever and Japanese encephalitis viruses. The study of a particularly effective monoclonal antibody, capable of protecting mice from lethal West Nile virus challenge even if administered 5 days after infection, has provided important information on the structural basis of viral neutralization. The work highlights the domain III region of the viral envelope protein as a potential target for both therapeutic antibodies and vaccines. The online version of this article (doi:10.1038/nature03956) contains supplementary material, which is available to authorized users. West Nile virus is a mosquito-borne flavivirus closely related to the human epidemic-causing dengue, yellow fever and Japanese encephalitis viruses. In establishing infection these icosahedral viruses undergo endosomal membrane fusion catalysed by envelope glycoprotein rearrangement of the putative receptor-binding domain III (DIII) and exposure of the hydrophobic fusion loop. Humoral immunity has an essential protective function early in the course of West Nile virus infection. Here, we investigate the mechanism of neutralization by the E16 monoclonal antibody that specifically binds DIII. Structurally, the E16 antibody Fab fragment engages 16 residues positioned on four loops of DIII, a consensus neutralizing epitope sequence conserved in West Nile virus and distinct in other flaviviruses. The E16 epitope protrudes from the surface of mature virions in three distinct environments, and docking studies predict Fab binding will leave five-fold clustered epitopes exposed. We also show that E16 inhibits infection primarily at a step after viral attachment, potentially by blocking envelope glycoprotein conformational changes. Collectively, our results suggest that a vaccine strategy targeting the dominant DIII epitope may elicit safe and effective immune responses against flaviviral diseases. The online version of this article (doi:10.1038/nature03956) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
3.7
作者:
Hiramatsu, K;Tadano, M;Lai, CJ
通讯作者:
Lai, CJ
影响因子:
82.9
作者:
Oliphant, Theodore;Engle, Michael;Nybakken, Grant E;Doane, Chris;Johnson, Syd;Huang, Ling;Gorlatov, Sergey;Mehlhop, Erin;Marri, Anantha;Chung, Kyung Min;Ebel, Gregory D;Kramer, Laura D;Fremont, Daved H;Diamond, Michael S
通讯作者:
Diamond, Michael S
影响因子:
64.8
作者:
Modis, Y;Ogata, S;Harrison, SC
通讯作者:
Harrison, SC
影响因子:
64.8
作者:
HALSTEAD, SB;OROURKE, EJ
通讯作者:
OROURKE, EJ
影响因子:
4.8
作者:
Tio, Phaik Hooi;Jong, Wan Wui;Cardosa, Mary Jane
通讯作者:
Cardosa, Mary Jane